Seeking Alpha

Pfizer (PFE) completes the acquisition of NextWave Pharmaceuticals in deal worth an initial...

Pfizer (PFE) completes the acquisition of NextWave Pharmaceuticals in deal worth an initial $255M plus milestone amounts of up to $425M. With the purchase, Pfizer gains access to Quillivant XR, an FDA-approved treatment for attention deficit hyperactivity disorder (ADHD). (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|